Dermatomyositis and polymyositis in breast cancer patients: a case reports
- Authors: Ganshina IP1, Zhukova LG1, Burnevitch EZ2, Gordeeva OO1, Kondratieva OE1
-
Affiliations:
- N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
- I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 20, No 1 (2018)
- Pages: 42-44
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/27168
- ID: 27168
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
I P Ganshina
N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federationканд. мед. наук, вед. науч. сотр. отд-ния химиотерапии и комбинированного лечения злокачественных опухолей 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
L G Zhukova
N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federationд-р мед. наук, зав. отд-нием химиотерапии и комбинированного лечения злокачественных опухолей 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
E Z Burnevitch
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Email: ganshinainna77@mail.ru
канд. мед. наук, доцент каф. внутренних, профессиональных болезней и пульмонологии 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
O O Gordeeva
N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federationаспирант отд-ния химиотерапии и комбинированного лечения злокачественных опухолей 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
O E Kondratieva
N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federationординатор отд-ния химиотерапии и комбинированного лечения злокачественных опухолей 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
References
- Dalakas M.C, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362 (9388): 971.
- Zantos D, Zhang Y, Felson D. The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 1994; 21: 1855-9.
- Barnes B.E, Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 1976; 84 (1): 68.
- Sigurgeirsson B, Lindelöf B et al. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992; 326 (6): 363.
- Rai S.K, Choi H.K et al. Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. Rheumatology (Oxford). 2016; 55 (3): 461-9. Epub 2015 Sep 30.
- Mimori T, Imura Y et al. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 2007; 19 (6): 523.
- Brouwer R, Hengstman G.J. et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001; 60 (2): 116.
- Koenig M, Fritzler M.J et al. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 2007; 9 (4): R78.
- Колядина И.В., Поддубная И.В. Современные возможности терапии HER2-положительного рака молочной железы (по материалам клинических исследований). Современ. онкология. 2014; 4: 10-21.
- Колядина И.В., Поддубная И.В. и др. Гетерогенность рака молочной железы I стадии: биологическое и прогностическое значение. Злокачественные опухоли. 2015; 1: 31-42.
- Hendren E, Vinik O. Breast cancer and dermatomyositis: a case study and literature review. Curr Oncol 2017; 24 (5): e429-e433.